基于多影像风险生物标志物的高危头颈癌自适应推量靶区定义
结果显示三种影像风险标志物识别的肿瘤特征 largely distinct,单一影像可能不足以定义推量靶区。
要点
- 高FDG、低BV、低ADC亚体积仅部分重叠,Dice系数分别为10%、46%、15%。
- 三种参数并集占GTV的64%,低BV与低ADC并集在10次放疗后显著缩小57%。
- 单一影像模态可能无法充分定义头颈癌的推量靶区。
核心结论
- 高FDG摄取、低BV和低ADC作为头颈癌影像风险生物标志物识别 largely distinct 的肿瘤特征,单一影像模态可能无法充分定义推量靶区。
主要发现
- 放疗前高FDG、低BV、低ADC亚体积占原发GTV中位数分别为20%、21%、45%。
- BV与ADC的Spearman相关系数范围为-0.47至0.22,BV与FDG为-0.08至0.59,ADC与FDG为-0.68至0.25。
- FDG与BV、FDG与ADC、BV与ADC亚体积的Dice系数分别为10%、46%、15%。
- 三种参数并集占GTV的64%,低BV与低ADC并集放疗前占GTV的56%,10次放疗后显著缩小57%。
临床怎么用
- 头颈癌自适应推量靶区定义可能需要整合FDG摄取、灌注和弥散等多影像风险生物标志物,而非依赖单一模态。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Positron emission tomography with 18F-deoxyglucose (FDG), dynamic contrast-enhanced magnetic resonance imaging (MRI), and diffusion-weighted MRI each identify unique risk factors for treatment outcomes in head and neck cancer (HNC). Clinical trials in HNC largely rely on a single imaging modality to define targets for boosting. This study aimed to investigate the spatial correspondence of FDG uptake, perfusion, and the apparent diffusion coefficient (ADC) in HNC and their response to chemoradiation therapy (CRT) and to determine the implications of this overlap or lack thereof for adaptive boosting. METHODS AND MATERIALS: Forty patients with HNC enrolled in a clinical trial underwent FDG positron emission tomography-computed tomography before CRT and underwent dynamic contrast-enhanced and diffusion-weighted MRI scans before and during CRT. The gross tumor volume (GTV) of the primary tumor was contoured on post-gadolinium T1-weighted images. Tumor subvolumes with high FDG uptake, low blood volume (BV), and low ADC were created by using previously established thresholds. Spatial correspondences between subvolumes were analyzed using the Dice coefficient, and those between each pair of image parameters at voxel level were analyzed by Spearman rank correlation coefficients. RESULTS: Prior to CRT, the median subvolumes of high FDG, low BV, and low ADC relative to the primary GTV were 20%, 21%, and 45%, respectively. Spearman correlation coefficients between BV and ADC varied from -0.47 to 0.22; between BV and FDG, from -0.08 to 0.59; and between ADC and FDG, from -0.68 to 0.25. Dice coefficients between subvolumes of FDG and BV, FDG and ADC, and BV and ADC were 10%, 46%, and 15%, respectively. The union of the 3 parameters was 64% of the GTV. The union of the subvolumes of BV and ADC was 56% of the GTV before CRT but was reduced significantly by 57% after 10 fractions of radiation therapy. CONCLUSIONS: High FDG uptake, low BV, and low ADC as imaging risk biomarkers of HNC identify largely distinct tumor characteristics. A single imaging modality may not define the boosting target adequately.
引用
- Teng F, Aryal M, Lee J, et al. Adaptive Boost Target Definition in High-Risk Head and Neck Cancer Based on Multi-imaging Risk Biomarkers. Int J Radiat Oncol Biol Phys. 2017. PMID: 29428251. doi:10.1016/j.ijrobp.2017.12.269
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。